A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, WITHDRAWAL, SAFETY AND EFFICACY STUDY OF ORAL BARICITINIB IN PATIENTS FROM 1 YEAR TO LESS THAN 18 YEARS OLD WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA).

Datos básicos

ENSAYO CLÍNICO I4V-MC-JAHU 2017-004495-60 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2020

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

ELI LILLY AND COMPANY

Compartir